Most interestingly, this difference of soluble chemokine levels between early HCC (defined as BCLC 0/A) compared to cirrhotic control patients remained consistent in four out of nine chemokines (CXCL5, CXCL9, CXCL10, and CXCL11). The gene discussed is CXCL5; the disease is hepatocellular carcinoma.